Pathogenesis of Rhodococcus equi infection in mice: roles of virulence plasmids and granulomagenic activity of bacteria.
Virulence of Rhocococcus equi ATCC 33701 and its plasmid-cured derivative ATCC 33701P- was compared in BALB/c and C3H/HeJ mice in terms of bacterial growth kinetics and histological changes in the liver, spleen and lungs, and humoral immune responses. Injection with a sublethal dose of 10(6) ATCC 33701 in mice resulted in microabscess formation after rapid multiplication in the liver and spleen by day 4, and then the bacteria were gradually eliminated with the formation of granuloma and the production of specific antibodies against 15- to 17-kDa antigens of the virulent bacteria. By contrast, ATCC 33701P- was avirulent as shown by early elimination of viable bacteria and no evidence of net multiplication in the organs. Histopathological changes consisted of only slight, transient infiltration of neutrophils and macrophages in the liver. Although live ATCC 33701P- did not evoke any humoral or histological responses in the mice, a large inoculum (10(8)) of killed ATCC 33701 and ATCC 33701P- resulted in the formation of granuloma in the liver and accelerated extramedullary hemopoiesis in the spleen. These results suggest that the pathogenesis of R. equi infection involves at least two important virulence determinants, both of which play critical roles in the disease: one is the virulence plasmid, which is required for R. equi to resist and grow within host cells; and the other is the granulomagenic activity that is related to the lipids and nature of the cell wall of the species, which induces the characteristic pathological changes.
Takai
S
S
Department of Animal Hygiene, School of Veterinary Medicine and Animal Sciences, Kitasato University, Aomori, Japan.
Madarame
H
H
Matsumoto
C
C
Inoue
M
M
Sasaki
Y
Y
Hasegawa
Y
Y
Tsubaki
S
S
Nakane
A
A
D000193:Actinomycetales Infections / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D005260:Female; D006017:Glycolipids / Q000502:physiology; D006099:Granuloma / Q000209:etiology* / Q000473:pathology; D008107:Liver Diseases / Q000209:etiology* / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D009929:Organ Size; D010957:Plasmids; D016929:Rhodococcus equi / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity*; D013045:Species Specificity; D013154:Spleen / Q000473:pathology; D013158:Splenic Diseases / Q000209:etiology* / Q000473:pathology; D014774:Virulence / Q000235:genetics
D000907:Antibodies, Bacterial; D006017:Glycolipids